Basic Cardiovascular Sciences  /  GS06. Cardiac Metabolism in Health and Disease  /  Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure
Logo

American Heart Association

  203
  0

Final ID:

Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure

  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
    • Author Disclosures:
    Svati Shah: DO have relevant financial relationships ; Research Funding (PI or named investigator):nference:Active (exists now) ; Other (please indicate in the box next to the company name):Unlicensed patent:Active (exists now) ; Research Funding (PI or named investigator):Verily, Inc.:Active (exists now) ; Research Funding (PI or named investigator):Lilly, Inc.:Past (completed) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

GS06. Cardiac Metabolism in Health and Disease

Tuesday, 07/23/2024 , 01:30PM - 02:45PM

General Session

More abstracts on this topic:
Locking and Unlocking Cardiac Maturation

Kelly Daniel

One Carbon Metabolism Defect In Failing Hearts

Jung Jae Woo, Flam Emily, Bedi Kenneth, Jang Cholsoon, Rabinowitz Joshua, Margulies Kenneth, Arany Zoltan

More abstracts from these authors:
The Year in Genomic Medicine

Shah Svati, Schunkert Heribert

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Shah Svati

You have to be authorized to contact abstract author. Please, Login
Not Available